Good News For Cancer Patients in India Cell-Therapy To Go Cheaper
In the US, the treatment of cancer of the blood cells- leukaemia by CAR T-cell therapy costs $800,000-$900,000 (which is around Rs 6-7 crore)Cancer patients...
Continue ReadingIn the US, the treatment of cancer of the blood cells- leukaemia by CAR T-cell therapy costs $800,000-$900,000 (which is around Rs 6-7 crore)Cancer patients...
Continue ReadingIn the last financial year, the company had spent ₹143 crore on R&D and set up its state-of-the-art centre, where about 150 scientists are working.Hyderabad...
Continue ReadingLifespan Private Limited has received an approval from the Department of Ayush, government of Telangana for carrying out tests for the identity, purity, quality and...
Continue ReadingWith an aim of improving India’s position in the global pharmaceuticals market on the innovation index, the Narendra Modi government is preparing to launch a...
Continue ReadingConverge Biotech Private Limited, Hyderabad started by Mr. Arunkumar Bijjala in the year 2015, had more than 2 decades of experience working in reputed Pharmaceutical...
Continue ReadingHyderabad-based Dr Reddy’s Laboratories has acquired a portfolio of branded and generic injectable products from US-based Eton Pharmaceuticals.The portfolio includes the Biorphen (phenylephrine hydrocholoride) Injection...
Continue ReadingIndia’s first indigenously developed RBD protein subunit vaccine, Biological E’s Corbevax, is currently being used to inoculate children in the age group of 12 to...
Continue ReadingThe drug major on the other day said that it has entered into definitive agreements for further investment of Rs 25.90 crore in digital tech...
Continue Reading